The bill amends sections 28-405 and 28-416 of the Revised Statutes Cumulative Supplement, 2024, as part of the Uniform Controlled Substances Act, by introducing new substances to the controlled substances schedules, particularly under Schedule I. This includes the addition of various fentanyl-related compounds such as Meta-Fluorofentanyl and Para-Methoxyfuranyl fentanyl, while repealing the listing of Brorphine and certain previously included fentanyl-related substances. The bill also clarifies definitions and exclusions for controlled substances, notably specifying that psilocybin does not include any FDA-approved pharmaceutical compositions. These changes aim to enhance regulation in response to evolving drug trends and public health concerns, aligning state laws with federal standards.

Additionally, the bill revises penalties related to controlled substances, particularly for offenses involving minors and specific locations like schools. It establishes stricter penalties for adults who involve minors in drug-related activities and emphasizes treatment and counseling for those convicted of drug offenses. The bill also introduces new penalties for individuals aged eighteen or younger who violate specific laws related to motor vehicle licenses, including sanctions such as license impoundment and mandatory drug education classes. A provision to repeal original sections 28-405 and 28-416 indicates a significant update to the legal framework governing both controlled substances and motor vehicle operator's licenses.

Statutes affected:
Introduced: 28-405, 28-416
Final Reading: 28-405, 28-416
Slip Law: 28-405, 28-416